List of Tables
List of Figures
Report Guidance
GlobalData Clinical Trials Report Coverage
Clinical Trials by Region
Clinical Trials and Average Enrollment by Country
Top Five Countries Contributing to Clinical Trials in Asia-Pacific
Top Five Countries Contributing to Clinical Trials in Europe
Top Countries Contributing to Clinical Trials in North America
Top Five Countries Contributing to Clinical Trials in Middle East and Africa
Top Countries Contributing to Clinical Trials in Central and South America
Clinical Trials by G7 Countries: Proportion of Dyskinesia to Central Nervous System Clinical Trials
Clinical Trials by Phase in G7 Countries
Clinical Trials in G7 Countries by Trial Status
Clinical Trials by E7 Countries: Proportion of Dyskinesia to Central Nervous System Clinical Trials
Clinical Trials by Phase in E7 Countries
Clinical Trials in E7 Countries by Trial Status
Clinical Trials by Phase
In Progress Trials by Phase
Clinical Trials by Trial Status
Clinical Trials by End Point Status
Subjects Recruited Over a Period of Time
Clinical Trials by Sponsor Type
Prominent Sponsors
Top Companies Participating in Dyskinesia Therapeutics Clinical Trials
Prominent Drugs
Clinical Trial Profile Snapshots
Appendix
Abbreviations
Definitions
Research Methodology
Secondary Research
About GlobalData
Contact Us
Source

List of Tables
List of Tables
Dyskinesia Therapeutics, Global, Clinical Trials by Region, 2020*
Dyskinesia Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2020*
Dyskinesia Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2020*
Dyskinesia Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2020*
Dyskinesia Therapeutics Clinical Trials, Europe, Top Five Countries, 2020*
Dyskinesia Therapeutics Clinical Trials, North America, Top Countries, 2020*
Dyskinesia Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2020*
Dyskinesia Therapeutics Clinical Trials, Central and South America, Top Countries, 2020*
Proportion of Dyskinesia to Central Nervous System Clinical Trials, G7 Countries (%), 2020*
Dyskinesia Therapeutics, G7 Countries, Clinical Trials by Phase, 2020*
Dyskinesia Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2020*
Proportion of Dyskinesia to Central Nervous System Clinical Trials, E7 Countries (%), 2020*
Dyskinesia Therapeutics, E7 Countries, Clinical Trials by Phase, 2020*
Dyskinesia Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2020*
Dyskinesia Therapeutics, Global, Clinical Trials by Phase, 2020*
Dyskinesia Therapeutics, Global, Clinical Trials In Progress by Phase 2020*
Dyskinesia Therapeutics, Global, Clinical Trials by Trial Status, 2020*
Dyskinesia Therapeutics Clinical Trials, Global, by End Point Status, 2020*
Dyskinesia Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2015-2019
Dyskinesia Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2020*
Dyskinesia Therapeutics Clinical Trials, Global, Key Sponsors, 2020*
Dyskinesia Therapeutics Clinical Trials, Global, Top Companies by Phase, 2020*
Dyskinesia Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2020*

List of Figures
Dyskinesia Therapeutics, Global, Clinical Trials by Region (%), 2020*
Dyskinesia Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2020*
Dyskinesia Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2020*
Dyskinesia Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2020*
Dyskinesia Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2020*
Dyskinesia Therapeutics Clinical Trials, North America, Top Countries (%), 2020*
Dyskinesia Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2020*
Dyskinesia Therapeutics Clinical Trials, Central and South America, Top Countries (%), 2020*
Proportion of Dyskinesia to Central Nervous System Clinical Trials, G7 Countries (%), 2020*
Dyskinesia Therapeutics, G7 Countries, Clinical Trials by Phase, 2020*
Dyskinesia Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2020*
Proportion of Dyskinesia to Central Nervous System Clinical Trials, E7 Countries (%), 2020*
Dyskinesia Therapeutics, E7 Countries, Clinical Trials by Phase, 2020*
Dyskinesia Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2020*
Dyskinesia Therapeutics, Global, Clinical Trials by Phase (%), 2020*
Dyskinesia Therapeutics, Global, Clinical Trials In Progress by Phase, 2020*
Dyskinesia Therapeutics, Global, Clinical Trials by Trial Status, 2020*
Dyskinesia Therapeutics Clinical Trials, Global, by End Point Status, 2020*
Dyskinesia Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2015-2019
Dyskinesia Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2020*
Dyskinesia Therapeutics Clinical Trials, Global, Key Sponsors, 2020*
Dyskinesia Therapeutics Clinical Trials, Global, Top Companies by Phase, 2020*
Dyskinesia Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2020*
GlobalData Methodology

Companies Mentioned
- Neurocrine Biosciences Inc
- AbbVie Inc
- Ipsen SA
- Teva Pharmaceutical Industries Ltd
- Merz Pharma GmbH & Co KgaA
- Novartis AG
- Addex Therapeutics Ltd
- The Lundbeck Foundation
- Eisai Co Ltd
- Jazz Pharmaceuticals Plc